102 related articles for article (PubMed ID: 28463599)
1. Growth Kinetics of Macronodular Lung Metastases and Survival in Differentiated Thyroid Carcinoma.
Kim M; Kim WG; Park S; Kwon H; Jeon MJ; Lee SM; Lee JH; Kim TY; Shong YK; Kim WB
Thyroid; 2017 Jul; 27(7):915-922. PubMed ID: 28463599
[TBL] [Abstract][Full Text] [Related]
2. Estimating the Growth Rate of Lung Metastases in Differentiated Thyroid Carcinoma: Response Evaluation Criteria in Solid Tumors or Doubling Time?
Song E; Ahn J; Jeon MJ; Lee SM; Lee JH; Kim TY; Baek JH; Kim WB; Shong YK; Kim WG
Thyroid; 2020 Mar; 30(3):418-424. PubMed ID: 31880976
[No Abstract] [Full Text] [Related]
3. Initial Size of Metastatic Lesions Is Best Prognostic Factor in Patients with Metastatic Differentiated Thyroid Carcinoma Confined to the Lung.
Kim M; Kim WG; Park S; Kwon H; Jeon MJ; Lee JJ; Ryu JS; Kim TY; Shong YK; Kim WB
Thyroid; 2017 Jan; 27(1):49-58. PubMed ID: 27750021
[TBL] [Abstract][Full Text] [Related]
4. Iodine-131 treatment and high-resolution CT: results in patients with lung metastases from differentiated thyroid carcinoma.
Ilgan S; Karacalioglu AO; Pabuscu Y; Atac GK; Arslan N; Ozturk E; Gunalp B; Ozguven MA
Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):825-30. PubMed ID: 14762699
[TBL] [Abstract][Full Text] [Related]
5. Prognostic indicators of outcomes in patients with lung metastases from differentiated thyroid carcinoma during long-term follow-up.
Sohn SY; Kim HI; Kim YN; Kim TH; Kim SW; Chung JH
Clin Endocrinol (Oxf); 2018 Feb; 88(2):318-326. PubMed ID: 28972676
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in pediatric differentiated thyroid cancer patients with pulmonary metastases.
Bal CS; Garg A; Chopra S; Ballal S; Soundararajan R
J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):745-51. PubMed ID: 25210762
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factors.
Song HJ; Qiu ZL; Shen CT; Wei WJ; Luo QY
Eur J Endocrinol; 2015 Sep; 173(3):399-408. PubMed ID: 26104753
[TBL] [Abstract][Full Text] [Related]
8. Clinical management and outcomes in patients with hyperfunctioning distant metastases from differentiated thyroid cancer after total thyroidectomy and radioactive iodine therapy.
Qiu ZL; Shen CT; Luo QY
Thyroid; 2015 Feb; 25(2):229-37. PubMed ID: 25331724
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis.
Pellegriti G; Giuffrida D; Scollo C; Vigneri R; Regalbuto C; Squatrito S; Belfiore A
Cancer; 2002 Nov; 95(10):2076-85. PubMed ID: 12412160
[TBL] [Abstract][Full Text] [Related]
10. Tumor volume doubling time of pulmonary metastases predicts overall survival and can guide the initiation of multikinase inhibitor therapy in patients with metastatic, follicular cell-derived thyroid carcinoma.
Sabra MM; Sherman EJ; Tuttle RM
Cancer; 2017 Aug; 123(15):2955-2964. PubMed ID: 28369717
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes and prognostic factors of patients with lung metastases from differentiated thyroid cancer after radioiodine therapy in Japan.
Akatani N; Wakabayashi H; Kayano D; Inaki A; Takata A; Hiromasa T; Yamase T; Kunita Y; Watanabe S; Mori H; Saito S; Nakajima K; Kinuya S
Endocr J; 2023 Mar; 70(3):315-322. PubMed ID: 36567077
[TBL] [Abstract][Full Text] [Related]
12. Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the M. D. Anderson experience.
Cabanillas ME; Waguespack SG; Bronstein Y; Williams MD; Feng L; Hernandez M; Lopez A; Sherman SI; Busaidy NL
J Clin Endocrinol Metab; 2010 Jun; 95(6):2588-95. PubMed ID: 20392874
[TBL] [Abstract][Full Text] [Related]
13. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
Haq M; Harmer C
Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
[TBL] [Abstract][Full Text] [Related]
14. Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors.
Lee J; Soh EY
Ann Surg; 2010 Jan; 251(1):114-9. PubMed ID: 19779325
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological characteristics and long-term outcome in patients with distant metastases from differentiated thyroid cancer.
Benbassat CA; Mechlis-Frish S; Hirsch D
World J Surg; 2006 Jun; 30(6):1088-95. PubMed ID: 16736341
[TBL] [Abstract][Full Text] [Related]
16. Outcomes and Prognostic Factors in Radioiodine Refractory Differentiated Thyroid Carcinomas.
Wassermann J; Bernier MO; Spano JP; Lepoutre-Lussey C; Buffet C; Simon JM; Ménégaux F; Tissier F; Leban M; Leenhardt L
Oncologist; 2016 Jan; 21(1):50-8. PubMed ID: 26675742
[TBL] [Abstract][Full Text] [Related]
17. Papillary thyroid carcinomas with lung metastases.
Lin JD; Chao TC; Chou SC; Hsueh C
Thyroid; 2004 Dec; 14(12):1091-6. PubMed ID: 15650364
[TBL] [Abstract][Full Text] [Related]
18. Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables.
Casara D; Rubello D; Saladini G; Masarotto G; Favero A; Girelli ME; Busnardo B
J Nucl Med; 1993 Oct; 34(10):1626-31. PubMed ID: 8410272
[TBL] [Abstract][Full Text] [Related]
19. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
20. Lung metastases from differentiated thyroid carcinoma: prognostic factors related to remission and disease-free survival.
Chopra S; Garg A; Ballal S; Bal CS
Clin Endocrinol (Oxf); 2015 Mar; 82(3):445-52. PubMed ID: 25040494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
